Welcome to our dedicated page for AMPHENOL /DE/ SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMPHENOL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMPHENOL /DE/'s regulatory disclosures and financial reporting.
Amphenol Corporation reported strong Q3 2025 results. Net sales were $6,194.4, up from $4,038.8 a year ago, and net income attributable to the company was $1,245.7 versus $604.4. Diluted EPS was $0.97 (basic $1.02). For the first nine months, net sales reached $16,655.7 and net income was $3,074.8, reflecting broad growth following recent acquisitions.
Operating cash flow for the nine months was $3,652.5, ending the quarter with cash and equivalents of $3,799.3. Total assets rose to $27,143.0, with total debt of $8,067.1 and long‑term debt of $7,129.5. The company issued $750.0 of 4.375% Senior Notes due 2028 and €600.0 of 3.125% Senior Notes due 2032, repaid its 2.050% Senior Notes due March 2025, and kept new $2,000.0 three‑year and $2,000.0 364‑day delayed draw term loans undrawn, expected for the planned CCS Business acquisition. A quarterly dividend of $0.165 per share was declared. Shares outstanding were 1,224,055,508 as of October 21, 2025. The company also noted tax notices to certain China subsidiaries with aggregate potential exposure up to approximately $200.
Form 144 notice: A shareholder filed to sell up to 365,118 shares of common stock, with an aggregate market value of $49,163,430.79. The filing lists an approximate sale date of 10/24/2025 and identifies the NYSE as the exchange, with Morgan Stanley Smith Barney LLC Executive Financial Services as broker.
The shares were acquired on 10/24/2025 through a cash exercise of options under a registered plan from the issuer. Shares outstanding were 1,220,921,111.
Amphenol Corporation (APH) furnished an 8-K announcing it issued a press release with financial results for the quarter and nine months ended September 30, 2025. The release is provided as Exhibit 99.1 and incorporated by reference.
The information under Item 2.02 is being furnished, not filed, which limits certain liabilities under the Exchange Act. The company also included customary forward-looking statements cautionary language.
Peter Straub, an officer (President, ISS Division) of Amphenol Corporation (APH), reported option exercises and simultaneous open-market sales on 09/08/2025. He exercised two stock option grants: one with a $22.37 exercise price (44,000 shares exercisable 05/23/2020, expiring 05/23/2029) and one with a $22.55 exercise price (44,000 shares exercisable 05/21/2021, expiring 05/21/2030). On the same date he sold 88,000 Class A shares in multiple trades at a weighted average sale price of $110.6357 (individual trades ranged $110.55–$111.035). After these transactions he held 176,000 Class A shares directly related to outstanding options and reported 0 Class A shares owned following the sales for the exercised tranches.
Form 144 filed for Amphenol Corporation (APH) reports a proposed sale of 88,000 common shares acquired on 09/08/2025 by exercise of options under a registered plan. The filing lists Morgan Stanley Smith Barney LLC as the broker and shows an aggregate market value of $9,735,941.60 for the shares, with approximately 1,220,921,111 shares outstanding. The filer indicates payment was made in cash on 09/08/2025 and reports no other sales in the past three months. The notice includes the required representation that the seller has no undisclosed material adverse information about the issuer.
Walter Luc, an officer and director of Amphenol Corporation (APH), reported a change in beneficial ownership on 08/29/2025. The Form 4 shows a gift (Code G) disposing of 18,048 shares of Class A common stock at a reported per-share price of $110.81. After the transaction, Mr. Luc is reported to beneficially own 433,742 shares, held directly. The filing was signed by a power of attorney on 09/02/2025. The document contains no earnings or other corporate action details; it solely discloses this insider transfer.
Amended Form 4 for APH reporting correction to prior insider filing. The filing shows that on 08/18/2025 the reporting person disposed of 76,400 shares of Class A common stock. Following the reported transactions the reporting person beneficially owns 25,000 shares indirectly through a 2025 GRAT #1 and 0 shares indirectly through a 2024 Irrevocable Trust. The amendment states a previously filed Form 4 (filed 08/19/2025) incorrectly reported that the 2024 Irrevocable Trust beneficially owned non-derivative securities; this amendment corrects the beneficial ownership amounts. The form is signed by Lance E. D'Amico and identifies his role as Sr. VP, Secretary & General Counsel of Amphenol Corporation.
Amphenol (APH) insider changes: Senior VP, Human Resources David M. Silverman reported transactions dated 08/25/2025. He exercised 100,000 stock options with an exercise price of $18.23 (options issued 05/19/2018, expiring 05/19/2027) and thereby acquired 100,000 Class A shares. On the same date he sold 100,000 Class A shares at a weighted average sale price of $110.4203 (trades ranged $109.90 to $110.59). Following the reported transactions the filing shows 12,500 Class A shares beneficially owned directly and 14,000 Class A shares indirectly through the 2025 GRAT #1.
Amphenol Corporation (APH) furnished an 8-K disclosing that it entered two credit facilities on August 22, 2025: a Three-Year Term Loan Credit Agreement and a 364-Day Term Loan Credit Agreement, each among the company, certain subsidiaries, a syndicate of financial institutions and JPMorgan Chase Bank, N.A. as administrative agent. The filing lists these agreements as Exhibits 10.1 and 10.2 and includes an interactive data cover page. The form is signed by Craig A. Lampo, Senior Vice President and Chief Financial Officer, on August 25, 2025.
These exhibits indicate new or replaced borrowing arrangements were executed, but the filing text provided here does not disclose loan amounts, pricing, covenants, maturity details beyond the term lengths, or use of proceeds. Without those specifics, the precise financial impact on liquidity, leverage, or interest expense cannot be determined from this extract alone.
Form 144 filed for Amphenol Corporation (APH) shows a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $11,042,030.00 and reported shares outstanding of 1,220,921,111. The filing states the securities were acquired by exercise of options under a registered plan on 08/25/2025 and payment was in cash. The document also lists a sale by David Silverman of 100,000 common shares on 05/30/2025 that generated $8,909,350.00 in gross proceeds. The filer affirms no undisclosed material adverse information and includes the standard Rule 144 representations and signature warning regarding intentional misstatements.